Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 21 of 21
DNA damage signatures and practical use
Serena Nik-Zainal
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Imaging therapy failure and cancer invasion
Erik Sahai
The Francis Crick Institute, London, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 8:00 AM-10:00 AM
Analysis and therapeutic targeting of Hodgkin Lymphoma tumor microenvironment
Margaret A. Shipp
Dana-Farber Cancer Institute, Boston, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 8:00 AM-10:00 AM
Virus mimicry and pattern recognition receptor activation by exosomes in the tumor microenvironment
Andy J. Minn
Abramson Family Cancer Research Inst., Philadelphia, PA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 8:00 AM-10:00 AM
Comprehensive enumeration of infiltrating immune cells in triple negative breast cancer using multiplexed ion beam imaging
Michael Angelo
Stanford University School of Medicine, Palo Alto, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 8:00 AM-10:00 AM
Personal regulome navigation
Howard Y. Chang
Stanford Univ., Stanford, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 10:20 AM-12:20 PM
Transcriptional addiction in cancer
James E. Bradner
Novartis Institutes for BioMedical Research, Cambridge, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 10:20 AM-12:20 PM
Histone-3K27M mutant diffuse midline gliomas of childhood: Epigenetic pathogenesis and therapeutic opportunities
Michelle Monje
Stanford Univ. School of Medicine, Stanford, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 10:20 AM-12:20 PM
Targeting essential transcriptional networks in lymphoma
Louis M. Staudt
National Cancer Institute, Bethesda, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 10:20 AM-12:20 PM
Novel mechanisms of PARP inhibitor resistance
Alan D. D'Andrea
Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Precision therapeutics with DNA-damaging agents
Yves G. Pommier
NCI-CCR, Bethesda, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Targeting stromal niche for the treatment of bone metastasis
Yibin Kang
Princeton University, Princeton, NJ, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Precision medicine for melanoma
Richard M. Marais
Cancer Research UK Manchester Institute, Manchester, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
The teamwork of neutrophils and cancer
Ilaria Malanchi
The Francis Crick Institute, London, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Heterogeneity in androgen receptor and IL-1beta expression by prostate cancer cells in skeletal metastases
Asurayya A Worrede-Mahdi
Drexel University College of Medicine, Philadelphia, PA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Cellular plasticity in cancer: Driving force and therapeutic target
Thomas Brabletz
Univ. of Erlangen, Erlangen, Germany
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Epigenetics: A gatekeeper to DNA amplification
Johnathan R. Whetstine
Harvard Medical School and, Charlestown, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Brachyury and the interleukin-8 axis in tumor progression
Claudia Palena
NCI-CCR, Bethesda, MD, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Circulating tumor DNA analysis for personalized cancer detection and monitoring
Maximilian Diehn
Stanford Univ., Stanford, CA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Molecular detection and characterization of circulating tumor cells
Daniel A. Haber
Massachusetts General Hospital, Charlestown, MA, United States
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
Liquid biopsies for the management of cancer patient treatment and for early detection of cancer
Caroline Dive
Cancer Research UK Manchester Inst., Manchester, United Kingdom
from 2017 Molecular Targets and Cancer Therapeutics conference on October 29, 2017 4:30 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 21 of 21